Clinical trials: Covid-19 Patients
Post-Acute COVID-19 Syndrome
Acute Cardiovascular Responses to a Single Exercise Session in Patients With Post-COVID-19 Syndrome
The objective of the study is to compare the acute cardiorespiratory and perceptual responses to a physical exercise session in those infected by Covid-19 with and without persistent symptoms.
- Trial name
- ExPostCovid-19 (NCT06248151)
- Testing
- Exercise session, Control session
- Where
- Brazil
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- University of Nove de Julho
COVID-19
Nutrition and LOComotoric Rehabilitation in Long COVID-19
Long COVID is a new phenomenon, in which individuals who experienced a SARS-CoV-2 infection still experience one or more symptoms, such as exercise intolerance, fatigue and/or muscle pains in addition to other COVID-related…
- Trial name
- UNLOCK (NCT05254301)
- Testing
- Intervention group
- Where
- Belgium
- Volunteers
- 65 people
- Sponsor
- Universitair Ziekenhuis Brussel
Coronavirus Disease 2019
Evaluate the Efficacy & Safety of Leronlimab in Patients With Severe or Critical COVID-19
The purpose of this study was assess the safety and efficacy of leronlimab (PRO 140) administered as weekly subcutaneous injection in subjects with severe or critical COVID-19 disease.
- Trial name
- NCT04347239
- Testing
- Leronlimab (700mg)
- Where
- 18 sites in United States
- Volunteers
- 484 people
- Sponsor
- CytoDyn, Inc.
Inflammatory Bowel Diseases
Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease
The aim of this study is to determine the impact of systemic immunosuppression on sustained antibody COVID-19 concentrations in patients with IBD who received a COVID-19 vaccine.
- Trial name
- NCT05014555
- Testing
- COVID-19 Vaccine
- Where
- 4 sites in United States
- Volunteers
- 400 people
- Sponsor
- GI Alliance
Type 2 Diabetes
Social Media-Delivered Patient Education in Enhancing Type 2 Diabetics Self-Management and Attitudes During the COVID-19 Pandemic
The current study was to develop a software "Line@" based health education program, providing video-based health information and communication between diabetes patients and health-care professionals.
- Trial name
- NCT04876274
- Testing
- TMU-LOVE
- Where
- Taiwan
- Volunteers
- 181 people, healthy volunteers welcome
- Sponsor
- Taipei Medical University
Covid19
EFFECTS OF INSPIRATORY MUSCLE TRAINING IN POST-COVID-19 PATIENTS
COVID-19 is an infectious disease caused by the SARS-CoV-2 virus, which had its first case identified in December 2019 in Wuhan, China.
- Trial name
- NCT05493410
- Testing
- TREATMENT GROUP (TG), CONTROL GROUP (CG)
- Where
- 2 sites in Brazil
- Volunteers
- 42 people
- Sponsor
- University Vila Velha
Severe COVID-19
Corticosteroids in Severe COVID-19(ASAP-C Study)
Administration of systemic corticosteroids for patients with severe forms of severe acute respiratory syndrome(SARS-Co-2) infection are recommended by several guidelines.
- Trial name
- ASAP-C (NCT04648410)
- Testing
- questionnaire
- Where
- Czechia
- Volunteers
- 2,000 people
- Sponsor
- Brno University Hospital
Covid19
Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients
At least 1 in 6 COVID-19 patients admitted to hospital to receive extra oxygen will die of complications. In patients with COVID-19, invasive treatment such as mechanical ventilation (e.g.
- Trial name
- NCT04500626
- Testing
- Oxygen
- Where
- 2 sites in Canada
- Volunteers
- 234 people
- Sponsor
- Ottawa Hospital Research Institute
COVID-19 Pneumonia
Phase 2b/3 Trial of NuSepin® in COVID-19 Pneumonia Patients
A Randomized, Double-blinded, Placebo-controlled, Parallel-treatment Group, Adaptive Design, Multi-center, Phase 2b/3 Trial to Evaluate Efficacy and Safety of NuSepin® Intravenous Infusion in COVID-19 Pneumonia Patients
- Trial name
- NCT05352347
- Testing
- NuSepin® 0.2 mg/kg, NuSepin® 0.4 mg/kg
- Where
- South Korea
- Volunteers
- 1,134 people
- Sponsor
- Shaperon
Covid19
Human Intravenous Interferon Beta-Ia Safety and Preliminary Efficacy in Hospitalized Subjects With COVID-19
This double-blinded, randomized study is being conducted to see if the investigational new drug called FP-1201-lyo - intravenous Interferon beta-1a, hereafter IV IFN beta-1a, can help patients recover more quickly from COVID-19…
- Trial name
- HIBISCUS (NCT04860518)
- Testing
- IFN beta-1a, Dexamethasone
- Where
- 4 sites in United States
- Volunteers
- 7 people
- Sponsor
- Faron Pharmaceuticals Ltd
COVID-19 Infection
A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy of Lavandula Angustifolia Containing Nasal Spray Medical Device in Preventing Deterioration of COVID-19 in Symptomatic Patients
A Nasal Spray device containing Dead Sea minerals and plant extracts, used to shorten duration and mitigate effects of Covid-19 infection in mild to moderate adult patients
- Trial name
- NCT04974190
- Testing
- Nasal Spray Device
- Volunteers
- 550 people, healthy volunteers welcome
- Sponsor
- The Grasses of Eden Ltd
Covid19, SARS-CoV Infection
Initial CT Findings and CO-RADS Stage in COVID-19
This study aims to determine whether patients with different real-time reverse transcriptase-polymerase chain reaction (PCR), chest computed tomography (CT) and laboratory findings have different clinical outcomes.
- Conditions
- Covid19, SARS-CoV Infection, Pneumonia, Viral
- Trial name
- NCT04789447
- Where
- 2 sites in Turkey (Türkiye)
- Volunteers
- 895 people
- Sponsor
- Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Covid19
Case Fatalities in Hospitalised COVID-19 Patients in the UK
This study will investigate how the case fatality in hospitalised patients with COVID-19 has changed throughout the pandemic. It will also explore possible mechanisms that could be driving these changes.
- Trial name
- NCT04527458
- Testing
- Patient Characteristics, COVID-19 treatments, Differences in triage
- Where
- United Kingdom
- Volunteers
- 70,000 people
- Sponsor
- University of Edinburgh
COVID
Sofosbuvir in Treatment of COVID 19
Sofosbuvir containing treatment in treatment of COVID 19 Egyptian patients
- Trial name
- NCT04460443
- Testing
- sofosbuvir, Sofosbuvir ledipsavir, Daclatasvir
- Where
- Egypt
- Volunteers
- 60 people
- Sponsor
- Tanta University
Covid19, Acute Respiratory Failure
Survival Rates and Longterm Outcomes After COVID-19
The study 'Survival rates and long-term outcomes for patients with COVID-19 admitted to Norwegian ICUs' is a national observational study, including patients admitted to a Norwegian ICU between March 2020 and March 2021.
- Conditions
- Covid19, Acute Respiratory Failure, Acute Respiratory Distress Syndrome, Post Intensive Care Unit Syndrome
- Trial name
- NCT04601090
- Testing
- ICU treatment
- Where
- Norway
- Volunteers
- 860 people
- Sponsor
- Oslo University Hospital
Covid19
Adhesive Tape Placement on Patients' Masks in the Emergency Department Increases Compliance of Proper Face Mask Use
Methods 123 patients were enrolled in a randomized controlled trial at Eskenazi Hospital from April 2020 until October 2020. We permitted patients to either use their own mask (due to low resources institutionally) or we provided…
- Trial name
- NCT04812184
- Testing
- Tape Face Mask
- Where
- United States
- Volunteers
- 123 people, healthy volunteers welcome
- Sponsor
- Indiana University
Septic Shock, Endotoxemia
Evaluating the Use of Polymyxin B Cartridge Hemoperfusion for Patients With Septic Shock and COVID 19
Prospective, observational, clinical investigation of PMX cartridge use in COVID 19 patients with septic shock
- Conditions
- Septic Shock, Endotoxemia, COVID, Corona Virus Infection
- Trial name
- NCT04352985
- Testing
- Toraymyxin PMX-20R (PMX Cartridge)
- Where
- 3 sites in United States
- Sponsor
- Spectral Diagnostics (US) Inc.
Covid19
Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19
This Clinical Trial evaluates nasal administration of Dexamethasone as an adjuvant treatment strategy for non-critically ill hospitalized participants with SARS CoV-2 infection.
- Trial name
- NCT04513184
- Testing
- IV Dexamethasone, Nasal Dexamethasone
- Where
- 3 sites in Mexico
- Volunteers
- 66 people
- Sponsor
- Edda Sciutto Conde
COVID-19
Efficacy of TCM Capsules Lian Hua Qing Wen Jiao Nang in Mild COVID-19 Patients
This research aims to investigate the adjuvant effect of LH in reducing the symptomatic duration of fully vaccinated, mild COVID-19 patients on home recovery program in Singapore.
- Trial name
- NCT05275933
- Testing
- TCM intervention
- Where
- 2 sites in Singapore
- Volunteers
- 93 people
- Sponsor
- Singapore Chung Hwa Medical Institution
Nervous System Diseases
Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Tianeptine in the Treatment of Covid Fog Symptoms in Patients After COVID-19.
COVID-19 is associated with a high risk of complications from the central nervous system. Syndrome of cognitive disorders- in terms of memory, attention or executive functions among COVID-19 convalescents is often called brain…
- Trial name
- COVMENT (NCT06012552)
- Testing
- Tianeptine
- Where
- Poland
- Volunteers
- 140 people
- Sponsor
- Military Institute od Medicine National Research Institute
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.